Holen Sie sich die Stockscreener-App
24.46
0.41%
-0.10
Handel nachbörslich:
24.75
0.29
+1.19%
Schlusskurs vom Vortag:
$24.56
Offen:
$24.91
24-Stunden-Volumen:
1.45M
Relative Volume:
1.45
Marktkapitalisierung:
$1.79B
Einnahmen:
$2.82B
Nettoeinkommen (Verlust:
$-1.87B
KGV:
-0.8767
EPS:
-27.9
Netto-Cashflow:
$-96.80M
1W Leistung:
-7.91%
1M Leistung:
-31.92%
6M Leistung:
-38.31%
1J Leistung:
-37.41%
1-Tages-Spanne:
$24.38
$25.39
1-Wochen-Bereich:
$23.77
$26.50
52-Wochen-Spanne:
$23.77
$49.45
Quidelortho Corporation Stock (QDEL) Company Profile
Firmenname
Quidelortho Corporation
Sektor
Branche
Telefon
(858) 552-1100
Adresse
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Vergleichen Sie QDEL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
24.46 | 1.79B | 2.82B | -1.87B | -96.80M | -27.90 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-09-19 | Fortgesetzt | UBS | Neutral |
| 2024-09-05 | Hochstufung | Craig Hallum | Hold → Buy |
| 2024-03-04 | Herabstufung | UBS | Neutral → Sell |
| 2024-02-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-14 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-19 | Eingeleitet | Citigroup | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Sell |
| 2022-06-17 | Fortgesetzt | JP Morgan | Neutral |
| 2022-02-22 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-03-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Bestätigt | Barclays | Overweight |
| 2018-01-04 | Hochstufung | CL King | Neutral → Buy |
| 2017-09-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Bestätigt | Canaccord Genuity | Hold |
| 2017-02-17 | Eingeleitet | CL King | Neutral |
| 2016-12-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Bestätigt | Barclays | Overweight |
| 2016-02-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-12-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Eingeleitet | Barclays | Overweight |
| 2013-07-31 | Bestätigt | Canaccord Genuity | Buy |
| 2011-03-03 | Herabstufung | Wedbush | Outperform → Neutral |
Alle ansehen
Quidelortho Corporation Aktie (QDEL) Neueste Nachrichten
QuidelOrtho Co. (NASDAQ:QDEL) Position Reduced by Bank of Montreal Can - Defense World
QuidelOrtho (NASDAQ:QDEL) Reaches New 52-Week Low on Analyst Downgrade - Defense World
QuidelOrtho Corporation (QDEL) receives a Buy rating from Citigroup - knoxdaily.com
QuidelOrtho Co. (NASDAQ:QDEL) Shares Sold by Russell Investments Group Ltd. - Defense World
Alliancebernstein L.P. Increases Stock Position in QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
Drug Screening Market Size Worth USD 10.34 Billion by 2034 | CAGR of 4.84% from 2025 to 2034 - GlobeNewswire Inc.
Quidel stock hits 52-week low at $25 amid market challenges By Investing.com - Investing.com South Africa
Quidel stock hits 52-week low at $25 amid market challenges - Investing.com Canada
Press Release Distribution & PR Platform - ACCESS Newswire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the Firm - marketscreener.com
QuidelOrtho (QDEL) Surges 10.1%: Is This an Indication of Further Gains? - MSN
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now - MSN
QuidelOrtho Co. (NASDAQ:QDEL) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
QuidelOrtho Corporation f/k/a Quidel Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your RightsQDEL - ACCESS Newswire
Orion Portfolio Solutions LLC Lowers Stock Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
QuidelOrtho Corporation f/k/a Quidel Corporation Class Action: Levi & Korsinsky Reminds QuidelOrtho Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024QDEL - ACCESS Newswire
Quidel stock hits 52-week low at $29.67 amid market challenges - Investing.com Australia
Medical Devices & SuppliesImaging, Diagnostics Stocks Q4 In Review: QuidelOrtho (NASDAQ:QDEL) Vs Peers - MSN
Quidel stock hits 52-week low at $29.67 amid market challenges By Investing.com - Investing.com South Africa
QuidelOrtho Co. (NASDAQ:QDEL) Shares Sold by Sei Investments Co. - Defense World
Raymond James Financial Inc. Makes New $2.17 Million Investment in QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
QuidelOrtho Corporation's (NASDAQ:QDEL) Business And Shares Still Trailing The Industry - simplywall.st
QuidelOrtho Corporation: What Is Their Latest Strategic Shift In Revenue Focus? - Smartkarma
Victory Capital Management Inc. Buys 8,493 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Charles Schwab Investment Management Inc. Acquires 148,735 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
QuidelOrtho Unveils Results Manager System to Streamline Testing - MSN
QuidelOrtho launches Results Manager system for hospitals - MSN
Bank of New York Mellon Corp Cuts Stock Position in QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
QuidelOrtho® Introduces Results Manager™ System - Quantisnow
QuidelOrtho launches new lab informatics system - Investing.com India
QuidelOrtho launches new lab informatics system By Investing.com - Investing.com South Africa
QuidelOrtho Co. (NASDAQ:QDEL) Shares Bought by Mutual of America Capital Management LLC - Defense World
QuidelOrtho Corp Reports Q4 Revenue of $708M, Exceeding Estimates; EPS Misses with $2.28 Loss - GuruFocus.com
Proficio Capital Partners LLC Acquires New Stake in QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
QuidelOrtho shares surge 49% following July 2024 undervalued signal By Investing.com - Investing.com Canada
QuidelOrtho shares surge 49% following July 2024 undervalued signal - Investing.com India
Quidel Ortho at Raymond James Conference: Strategic Growth and Efficiency - Investing.com
Is QuidelOrtho Corporation (QDEL) the Best Medical Technology Stock to Buy According to Analysts? - Insider Monkey
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Corporation Investors Can Join the Class Action Lawsuit! - ACCESS Newswire
QDEL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds QuidelOrtho Corporation Investors to Join the Class Action Lawsuit - ACCESS Newswire
Shareholders that lost money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
QuidelOrtho Full Year 2024 Earnings: EPS Misses Expectations - Simply Wall St
9,598 Shares in QuidelOrtho Co. (NASDAQ:QDEL) Acquired by Sanctuary Advisors LLC - Defense World
Investors who lost money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) should contact Levi & Korsinsky about pending Class ActionQDEL - ACCESS Newswire
QDEL LAWSUIT ALERT: Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Phocas Financial Corp. Sells 66,923 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Rhumbline Advisers Purchases 12,026 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Finanzdaten der Quidelortho Corporation-Aktie (QDEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):